Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
ME-344
print preview
bookmark
share with colleague
General Information
Company
MEI Pharma Inc.
Description
Mitochondrial inhibitor and an active metabolite of NV-128, a first-generation compound
Molecular Target
Mechanism of Action
Latest Stage of Development
Phase I
Indication
Solid tumors
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy